| Product NDC: | 60505-0033 |
| Proprietary Name: | PENTOXIFYLLINE |
| Non Proprietary Name: | PENTOXIFYLLINE |
| Active Ingredient(s): | 400 mg/1 & nbsp; PENTOXIFYLLINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60505-0033 |
| Labeler Name: | Apotex Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075191 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19990610 |
| Package NDC: | 60505-0033-7 |
| Package Description: | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-0033-7) |
| NDC Code | 60505-0033-7 |
| Proprietary Name | PENTOXIFYLLINE |
| Package Description | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-0033-7) |
| Product NDC | 60505-0033 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PENTOXIFYLLINE |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19990610 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp. |
| Substance Name | PENTOXIFYLLINE |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |